These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1550784)

  • 1. Third party mediated graft rejection despite irradiation of blood products.
    Sproul AM; Chalmers EA; Mills KI; Burnett AK; Simpson E
    Br J Haematol; 1992 Feb; 80(2):251-2. PubMed ID: 1550784
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran.
    Alimoghaddam K; Ghaffari H; Foroughi F; Chardouli B; Sanaat Z; Bahar B; Mousavi A; Iravani M; Ghavamzadeh A
    Arch Iran Med; 2006 Apr; 9(2):99-103. PubMed ID: 16649348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation.
    Przepiorka D; Ippoliti C; Koberda J; Chan KW; Khouri IF; Fischer HE; Huh YO; Escudier SM; Seong D; Davis M
    Transplantation; 1994 Oct; 58(7):858-60. PubMed ID: 7940725
    [No Abstract]   [Full Text] [Related]  

  • 4. Adoptive immunotherapy in human and canine chimeras.
    Kolb HJ; Mittermüller J; Günther W; Bartram C; Thalmaier K; Schumm M; Holler E; Lederose G
    Bone Marrow Transplant; 1993; 12 Suppl 3():S61-4. PubMed ID: 7510199
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Byrne M; Savani BN; Mohty M; Nagler A
    Exp Hematol; 2016 Jul; 44(7):567-73. PubMed ID: 27106798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion associated graft-versus-host disease in autologous bone marrow transplantation.
    Mulder NH; Elema JD; Postmus PE
    Lancet; 1989 Apr; 1(8640):735-6. PubMed ID: 2564556
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of fingernail DNA for evaluation of chimerism after bone marrow transplantation and for diagnostic testing for transfusion-associated graft-versus-host disease.
    Uchida S; Wang L; Yahagi Y; Tokunaga K; Tadokoro K; Juji T
    Blood; 1996 May; 87(9):4015-6. PubMed ID: 8611737
    [No Abstract]   [Full Text] [Related]  

  • 9. Blaschkoid Acute Graft-vs-Host Disease.
    Gupta V; Arava S; Ramam M
    JAMA Dermatol; 2018 Apr; 154(4):494-495. PubMed ID: 29387872
    [No Abstract]   [Full Text] [Related]  

  • 10. Graft-versus-leukemia reactions in clinical bone marrow transplantation.
    Mehta J
    Leuk Lymphoma; 1993 Aug; 10(6):427-32. PubMed ID: 8401179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet irradiation for the prevention of graft-versus-host disease and graft rejection in bone marrow transplantation.
    Hudson JG; Lawler M; Pamphilon DH
    Bone Marrow Transplant; 1994 Oct; 14(4):511-6. PubMed ID: 7858525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
    Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
    Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
    Przepiorka D; Huh YO; Khouri I; Reading C; Hester J; Marshall M; Champlin RE
    Prog Clin Biol Res; 1994; 389():557-63. PubMed ID: 7700921
    [No Abstract]   [Full Text] [Related]  

  • 15. More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Working Party.
    Simonin M; Dalissier A; Labopin M; Willasch A; Zecca M; Mouhab A; Chybicka A; Balduzzi A; Volin L; Peters C; Bader P; Dalle JH
    Bone Marrow Transplant; 2017 Jul; 52(7):1071-1073. PubMed ID: 28394370
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rejection of allogeneic bone marrow transplant. Case report].
    Szczylik C; Ratajczak M; Dumański Z; Myc A; Siekierzyński M; Rybicki Z; Kłos M; Zaboklicki S; Zaborowski P; Nowakowska B
    Pol Arch Med Wewn; 1988 Jan; 79(1):30-7. PubMed ID: 3275168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The skin manifestations of the graft vs. host reaction].
    Biriukov AV; Baranov AE; Selidovkin GD; Evseeva LV; Getling ZM; Persina IS
    Vestn Dermatol Venerol; 1990; (5):16-9. PubMed ID: 2402935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect.
    Kloosterman TC; Martens AC; van Bekkum DW; Hagenbeek A
    Bone Marrow Transplant; 1995 Apr; 15(4):583-90. PubMed ID: 7655385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.
    Przepiorka D; Giralt S; Huh YO; Andreeff M; Luna M; Reading C; Thomas M; Champlin RE
    Transplant Proc; 1992 Dec; 24(6):2906-7. PubMed ID: 1465994
    [No Abstract]   [Full Text] [Related]  

  • 20. An unrelated donor bone marrow transplant (BMT) for the treatment of Philadelphia chromosome-positive acute lymphocytic leukemia.
    Aker SN; Vogelsan GB; Riley-Graves L; Manela EM; Stutzer CA; Beck J; Weisdorf S
    Cancer Pract; 1993; 1(4):268-72. PubMed ID: 8111436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.